Inari Medical (NARI) News Today

Ameritas Investment Partners Inc. cut its position in Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 67.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,539 shares of the company's stock after selling 11,448 shares during the period. Ameri

William Blair assumed coverage on shares of Inari Medical in a research report on Thursday. They set an "outperform" rating on the stock.

Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) CEO Andrew Hykes sold 3,000 shares of the firm's stock in a transaction that occurred on Monday, July 22nd. The stock was sold at an average price of $55.23, for a total value of $165,690.00. Following the completion of the sale, the chief executive officer now owns 455,252 shares of the company's stock, valued at approximately $25,143,567.96. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Clearbridge Investments LLC grew its stake in Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 41.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 249,618 shares of the company's stock af

Inari Medical (NASDAQ:NARI) will be releasing earnings after the market closes on Tuesday, July 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=609259)

Nwam LLC grew its holdings in shares of Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 44.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 31,935 shares of the company's stock after buying an additional 9,755 shares d

Inari Medical (NASDAQ:NARI) Shares Gap Down to $58.62

Motley Fool Asset Management LLC grew its holdings in shares of Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 46.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 64,677 shares of the company's stock after purchasing an additional 20,438 sha

Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) CFO Mitch C. Hill sold 5,000 shares of the stock in a transaction on Friday, July 12th. The shares were sold at an average price of $53.95, for a total transaction of $269,750.00. Following the sale, the chief financial officer now directly owns 179,227 shares of the company's stock, valued at approximately $9,669,296.65. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Truist Financial upped their target price on shares of Inari Medical from $47.00 to $60.00 and gave the stock a "hold" rating in a research note on Tuesday.

Mutual of America Capital Management LLC lowered its holdings in shares of Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 74.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,879 shares of the compan

Shares of Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and five have

Jennison Associates LLC decreased its position in Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 22.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 343,439 shares of the company's stock after selli

Maryland State Retirement & Pension System acquired a new stake in shares of Inari Medical, Inc. (NASDAQ:NARI - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 18,475 shares of the company's stock, valued at approximately $886,000. Severa